Introduction
Platelet-activating factor (PAF) is a phospholipid with a variety of biological functions, including signaling and activation of proinflammatory cells such as platelets and neu-years); the mean age of the parents was 40 years (range, 26 to 72 years). Criteria used to identify asthma patients have been described previously (Yokouchi et al. 2000) .
The families examined in this study are some of the same families that participated in our genome-wide study (Yokouchi et al. 2000) . Because we had obtained supportive evidence in our families for linkage of asthma to human chromosome 6p, where the PAFAH gene is located, in this study we examined only the proband (n ϭ 118) and parents (n ϭ 236) in each family represented. For the adult control, we determined the genotypes of 188 anonymous, unrelated, healthy Japanese women. Adult control subjects were not evaluated for asthma. We selected child controls who met all of the following criteria: (1) no symptoms or history of allergic diseases, (2) no detectable dust-mite-specific IgE antibody, and (3) total serum IgE levels below the general population mean for their ages. The mean age of the child controls was 11 years (range, 9 to 14). This study was approved by the Committee of Ethics of the University of Tsukuba.
The genotype of the Val279Phe polymorphism was determined by a polymerase chain reaction (PCR)-based, allele-specific method described previously (Stafforini et al. 1996) .
Allelic and genotypic TDTs were assessed with the SIB-PAIR program (http://www2.qimr.edu.au/davidD). A P value Ͻ 0.05 was considered statistically significant.
Results
The TDT revealed that transmission of the Phe279 allele to asthmatic children was not statistically significant: the transmitted alleles: nontransmitted alleles ratio for the Phe279 allele was 54 : 39 (P ϭ 0.14). However, the genotypic transmission test revealed a significant deviation from expected values. Among probands, 30 were homozygous for Val279, 37 were heterozygous, and 15 were homozygous for Phe279, whereas the expected numbers were 30.2, 44.0, and 7.8, respectively (P ϭ 0.02). Table 1 shows the genotypic distribution of the Val279Phe polymorphism of the PAFAH gene. The frequency of homozygosity of the Phe279 allele was significantly higher in asthmatic children than in the parents, adult controls, or child controls. The Phe279 allele was found more frequently in asthmatic children than it was in controls. The frequency of the Phe279 allele was also increased significantly in the parents of asthmatic children compared with in the controls. There was no statistical difference in the frequency of the Phe279 allele between asthmatic children and their parents.
Discussion
In this study, we confirmed an association between the Phe279 allele of the PAFAH gene and atopic asthma through case control comparisons. Case control studies are susceptible to hidden population stratifications, and inconsistent results between studies often result from different allele or genotype frequencies in the control groups rather than in the patient groups. The prevalence of homozygosity for Phe279 in our control subjects was similar to frequencies reported for other Japanese control populations (Hiramoto et al. 1997; Satoh et al. 1999; Stafforini et al. 1999) . The frequency of the Phe279 allele in the present study was also similar to frequencies reported previously. Therefore, our positive findings were not likely due to low prevalence of homozygosity for Phe279 in our control subjects. In addition, we found a significant association between Phe279 homozygosity and asthma in our families by comparing the prevalence between asthmatic children and their parents and by the results of the TDT analyses. Because homozygosity for Phe279 causes complete lack of PAFAH activity, the present study provides evidence for association between PAFAH deficiency and atopic asthma.
An association between the Val279Phe polymorphism and the severity of asthma was observed by Stafforini and colleagues (Stafforini et al. 1999) but not by Satoh and colleagues (Satoh et al. 1999) . The association between ho- PAFAH, platelet-activating factor acetylhydrolase; OR, odds ratio; CI, confidence interval a P ϭ 0.006 (OR ϭ 3.3, 95% CI 1.3-8.0) between asthmatic children and adult controls; P ϭ 0.02 (OR ϭ 3.3, 95% CI 1.2-8.8) between asthmatic children and nonasthmatic and nonatopic child controls; and P ϭ 0.02 (OR ϭ 2.5, 95% CI 1.2-5.4) between asthmatic children and parents, when comparisons were made between Phe/Phe and Val/Val ϩ Val/Phe b P ϭ 0.007 (OR ϭ 1.7, 95% CI 1.2-2.4) between asthmatic children and adult controls, P ϭ 0.004 (OR ϭ 1.8, 95% CI 1.2-2.7) between asthmatic children and nonasthmatic and nonatopic child controls, and P ϭ 0.03 (OR ϭ 1.4, 95% CI 1.0-2.0) between parents and controls mozygosity for Phe279 and atopic asthma in the present study is supported by an odds ratio of 3.3 with controls. This may be due to the homogeneous clinical characteristics of our patients with childhood mite-sensitive atopic asthma. Linkage of asthma to chromosome 6p21, where the PAFAH gene is located, was observed previously in our families (Yokouchi et al. 2000) . It is likely that the association between the homozygosity of the Phe279 allele and asthma accounts for this linkage, at least in part.
